Why PTC Therapeutics may have to lower the price on a $89,000-a-year drug it just bought
March 16, 2017 at 15:40 PM EDT
Analyst asks: What choice does PTC Therapeutics have but to “dramatically” lower the price?
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.